Related Experiment Video
Updated: Jun 22, 2026

Supervised Machine Learning for Semi-Quantification of Extracellular DNA in Glomerulonephritis
Published on: June 18, 2020
Recent developments in the classification and assessment of vasculitis
Richard A Watts1, David G I Scott
1School of Medicine, Health Policy and Practice, University of East Anglia, Norwich, UK. richard.watts@uea.ac.uk
Insights
Systemic vasculitides, characterized by blood vessel inflammation, lack clear causes, complicating classification. New algorithms harmonize existing criteria, but revised classification and diagnostic criteria are essential for clinical trials.
Area of Science:
- Rheumatology and Immunology
- Vascular Medicine
- Clinical Trial Design
Background:
- Systemic vasculitides are multisystem diseases involving blood vessel inflammation.
- The exact causes (aetiopathogenesis) remain unknown, leading to descriptive nomenclature and classification based on pathology.
- Standardized classification is crucial for conducting large-scale clinical trials.
Purpose of the Study:
- To address the need for revised classification and diagnostic criteria for systemic vasculitides.
- To harmonize existing classification systems, including the American College of Rheumatology (ACR) 1990 criteria and Chapel Hill Consensus Conference definitions.
- To highlight the importance of accurate assessment tools in clinical trials and practice.
Main Methods:
- Development of an algorithm to harmonize the ACR 1990 criteria and Chapel Hill Consensus Conference definitions.
- Review of existing standardized assessment tools for disease activity and damage.
- Discussion of the need for novel diagnostic criteria and revised classification schemes.
Main Results:
- An algorithm has been developed to harmonize current classification definitions.
- Existing assessment tools are widely used in clinical trials and practice.
- A need for new diagnostic criteria and revised classification remains.
Conclusions:
- Harmonization efforts have been made, but revised classification and de novo diagnostic criteria are still required for systemic vasculitides.
- Accurate and objective assessment tools are critical for effective clinical trials and patient management.
- Ongoing development of next-generation assessment tools is anticipated.
Abstract:
The systemic vasculitides are a group of multisystem diseases characterized by inflammation of blood vessels. The aetiopathogenesis is unknown, and therefore nomenclature and classification are often descriptive and based on pathological features. Generally agreed classification schemes are vital to enable large multicentre or multinational clinical trials to be undertaken. An algorithm has recently been developed to harmonize use of the American College of Rheumatology (ACR) 1990 criteria and the Chapel Hill Consensus Conference definitions. Despite this, a revision of the classification criteria is still needed, and diagnostic criteria need to be developed ab initio. The very complexity of the diseases makes accurate objective assessment critical, especially for the conduct of clinical trials. Several standardized assessment tools for both disease activity and damage have been developed over the past two decades and are now widely used in both clinical trials and routine practice. A second generation of tools is now under development.
Related Concept Videos
Nephrotic Syndrome II : Assessment and Medical Management
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Myocarditis II: Clinical Features and Diagnostic Tests
Endocarditis II: Clinical Features of Infective Endocarditis
